Issue link: https://viewer.e-digitaledition.com/i/962601
LONG-TERM TESTOSTERONE THERAPY IMPROVES uRINARY AND SExuAL FuNCTION IN HYPOGONADAL MEN, ACCORDING TO A RECENT STuDY. OTHER RECENT FINDINGS, HOWEVER, CONTINuE TO FuEL DEBATE AS TO WHETHER THE POTENTIAL BENEFITS OF THE TREATMENT OuTWEIGH THE RISKS. BY THOMAS CROCKER THE DEBATE CONTINUES IN MIDDLE-AGED AND older men, low levels of testosterone caused by age- related decline in its production ca n si g n i f ica nt ly reduce qua l it y of l i fe. Testosterone defi ciency (ma le hypogo- nadism) can lead to fatigue, muscle loss, low libido, erecti le dysf unction a nd lower urinary tract symptoms (LUTS), such as wea k strea m a nd incomplete bladder emptying. Testosterone therapy for older, symp- tomatic, hypogonadal men has long been contentious among clinicians, mainly due to fears of a link to prostate cancer. Studies have proved those concerns to be unfounded, according to Abdulmaged Tra ish, PhD, Professor of Urolog y at Boston University School of Medicine, but questions have rema ined about a possible association between testoster- one therapy and LUTS. Traish partnered with colleag ues at Boston University and in Germany to conduct a long-term, obser vat iona l, prospect ive st udy of testosterone therapy's eff ects on urinary and sexua l function, as well as qua lity of life. "The my th is that androgen [testos- t er on e] c a u s e s a bnor m a l pr o s t a t e growth," Traish says. "Benign prostatic hy per pl a si a t a ke s pl a c e on ly when a ndrogen begins to decline, though. I t h i n k t h is somehow ha s never been understood. The my th continues, and because it does, we think testosterone t h e r a p y i s goi n g t o m a k e u r i n a r y Testosterone Therapy for Older Hypogonadal Men: SPECIAL CLINICAL SECTION: MEN'S HEALTH 1 4

